Alliance for Cancer Gene Therapy (ACGT): 2015 Investigator's Award in Clinical Translation of Cell and Gene Therapy for Sarcoma

ACGT has released an RFP for research aimed at furthering the development of cell and gene therapy approaches to the treatment of cancer. This award is specifically for those conducting cell and gene therapy research for sarcoma. Award amount is up to $500,000 over 2-3 years. LOI deadline is Oct. 26, 2015 by 11 a.m.

The UNC Office of Corporate and Foundation Relations has identified the following private funding opportunity:

Alliance for Cancer Gene Therapy (ACGT): 2015 Investigator's Award in Clinical Translation of Cell and Gene Therapy for Sarcoma
http://www.acgtfoundation.org

ACGT funds research aimed at furthering the development of cell and gene therapy approaches to the treatment of cancer. This award is specifically for those conducting cell and gene therapy research for sarcoma. The PI must have an MD, PhD or equivalent degree and must be a tenure-track or tenured faculty. ACGT does not have citizenship restrictions, and research must be conducted at academic medical centers or research centers in the US or Canada. Grant applications are being accepted to produce and release-testing of the clinical trial agents under cGMP, conduct the necessary pre-clinical pharmacological and toxicological studies in appropriate animal models, and/or conducting the clinical translational trials in patients in support of a new investigative New Drug (IND) application to the FDA.

Abstract/LOI Deadline: October 26, 2015 by 11am EST. Notification of full proposal submission is November 13, with full proposals due January 18, 2016 by 11am EST. Application guidelines for the award can be found here: http://www.acgtfoundation.org/wp-content/uploads/2015/09/RFA-2015-Clinical-Translation-Sarcoma_The-Wendy-Walk-ACGT-Sarcoma-Research-Grant.pdf


The UNC Office of Corporate and Foundation Relations is available to provide assistance in pursuing privately funded opportunities. Email cfr@unc.edu or phone 919.962.3423. 

Filed under: